By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous antihyperlipidemic agents > Leqvio
Miscellaneous antihyperlipidemic agents

Leqvio

https://themeditary.com/drug/leqvio-8382.html
Medically Reviewed by Melisa Puckey, BPharm TheMediTary.Com | Reviewed: Sep 04, 2023  Additional Content by TheMediTary.Com

Generic name: inclisiran

Drug class: Miscellaneous antihyperlipidemic agents

Dosage form: subcutaneous injection (284 mg/1.5 ml)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Leqvio, Inclisiran, Inclisiran (systemic) (monograph)

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Leqvio?

Leqvio (inclisiran) is a prescription medicine used to lower LDL-C cholesterol levels for adults with certain types of high cholesterol (primary hyperlipidemia). Leqvio reduces ‘bad’ low-density lipoprotein cholesterol (LDL-C) and is used with diet and statin therapy. 

Leqvio works by blocking a protein in the liver, this increases  LDL-C clearance, which lowers the amount of 'bad' cholesterol in your blood. The protein it blocks is proprotein convertase subtilisin kexin type 9 (PCSK9). Leqvio is a small interfering RNA (siRNA) and was the first medication of its class to be approved to lower 'bad' LDL cholesterol. 

Leqvio is given as an injection under the skin (subcutaneous) as a first dose, then a second dose at 3 months, and then every 6 months after that.

What is Leqvio used for?

Leqvio is indicated for adults with primary hyperlipidemia, which is high cholesterol due to genetic abnormalities, including heterozygous familial hypercholesterolemia (HeFH). Leqvio should be used together with statin therapy and diet.

Leqvio originally received FDA approval on December 22, 2021, and the indications were expanded on July 10, 2023.

How should I take Leqvio

  • A healthcare professional will give you your injection, is injected under your skin (subcutaneously) into the abdomen, upper arm, or thigh. Do not inject in areas of active skin disease or injury, such as sunburn, skin rashes, inflammation, or skin infections.
  • This medicine is an add-on treatment to an improved diet and the maximum tolerated statin dose.
  • The injection is given as an initial dose, then repeated at 3 months, and then every 6 months after that.
  • Do not stop receiving this medication without talking to your healthcare provider, as your LDL cholesterol levels may increase.

Dosing information

The recommended dosage of Leqvio:

  •   284 mg given as a single subcutaneous injection initially, again at 3 months, and then every 6 months.

Leqvio is available in a single-dose prefilled syringe 284 mg/1.5 mL (189 mg/mL). 

Inclisiran is only part of a complete treatment program that includes diet, statin medication, and regular blood testing.

Detailed Leqvio dosage information
Leqvio Dosage information (more detail)

Before Taking

Do not receive this medicine if you are allergic to the active ingredient inclisiran or inactive ingredients in this medication. See below for a complete list of ingredients.

Tell your doctor if you use other medicines or have other medical conditions, including severe kidney disease, are receiving dialysis, or have severe liver disease.

You should not have this injection if you are under 18 years of age.

Pregnancy

Tell your doctor if you are pregnant, become pregnant, or plan to become pregnant. The use of this medicine should be avoided during pregnancy.

Breastfeeding

Tell your doctor if you are breastfeeding or plan to breastfeed. It is not yet known whether this medicine passes into human breast milk. Your doctor will consider the potential benefits of treatment for you and the risks to your baby compared to the risks of breastfeeding for your baby.

Leqvio pregnancy and breastfeeding warnings (more detail)

What happens if I miss a dose?

If you miss a dose of this medicine and it has been less than 3 months, then see your healthcare provider for a dose and continue with your original dosing schedule.

If you miss a dose of this medicine and it has been more than 3 months, then see your healthcare provider and restart with a new dosing schedule - starting with an initial dose, then another dose at 3 months, and then every 6 months after that.

What happens if I overdose?

There is no specific treatment for an overdose of this medicine If you receive too much, your healthcare provider will check you for side effects and treat any side effects as required.

Leqvio side effects

Common Leqvio side effects

  • redness, pain, or bruising where an injection was given;
  • pain in your legs and arms;
  • diarrhea;
  • breathing problems, bronchitis;
  • joint pain; or
  • pain and burning when you urinate (this is a serious side effect - call your doctor)

Serious Leqvio side effects

Get emergency medical help if you have signs of an allergic reaction: hives, severe itching, difficulty breathing, swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • pain and burning when you urinate.

This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See more: Leqvio Side Effects

More about Leqvio (Inclisiran)

Dosage information
Leqvio Side Effects
During pregnancy
Drug images
Side effects
Breastfeeding Warnings
Drug class: Miscellaneous antihyperlipidemic agents

Related treatment guides

High Cholesterol
High Cholesterol, Familial Heterozygous
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by